FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/088574 [Registered on: 10/06/2025] Trial Registered Prospectively
Last Modified On: 10/06/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of Topical Magnesium Spray and Elastic Band Exercises to Improve the Quality of Life in Adults with Radiating Back Pain. 
Scientific Title of Study   Effect of Transdermal Magnesium and Moderate Intensity TheraBand Training on Pressure, Pain Threshold, Disability and Quality of Life Among Adults with Sciatic Pain: A Randomized Controlled Trial  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sakshi Vats 
Designation  PhD Scholar 
Affiliation  GALGOTIAS University 
Address  School of Allied Health Sciences, Block B, Room No.325 Galgotias University, Noida, Uttar Pradesh

Gautam Buddha Nagar
UTTAR PRADESH
203201
India 
Phone  9992357385  
Fax    
Email  sakshivats186@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Sakshi Vats 
Designation  PhD Scholar 
Affiliation  GALGOTIAS University 
Address  School of Allied Health Sciences, Block B, Room No. 325, Galgotias University, Noida, Uttar Pradesh

Gautam Buddha Nagar
UTTAR PRADESH
203201
India 
Phone  9992357385  
Fax    
Email  sakshivats186@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Sakshi Vats 
Designation  PhD Scholar 
Affiliation  GALGOTIAS University 
Address  School of Allied Health Sciences, Block B, Room No. 325, Galgotias University, Noida, Uttar Pradesh

Gautam Buddha Nagar
UTTAR PRADESH
203201
India 
Phone  9992357385  
Fax    
Email  sakshivats186@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Sakshi Vats  
Address  Galgotias University, Noida, Uttar Pradesh, 203201 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Savita Kataria  Amar Jyoti Rehabilitation and Research Centre   Amar Jyoti Charitable Trust, Karkardooma, Delhi, 110092
East
DELHI 
9810081074

savitakpc@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SCHOOL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M959||Acquired deformity of musculoskeletal system, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Control Group   Patients in control group will receive TheraBand exercises along with placebo transdermal magnesium spray. Each exercise consists of 15-20 repetitions × 3 sets, with 3 sessions/week for 8 weeks.  
Intervention  Experimental Group (Transdermal Magnesium spray + TheraBand Exercises)  Transdermal magnesium spray: Patient will be in prone lying position; therapist will spray the magnesium spray over the course of sciatic nerve. A total number of 10 sprays will be applied over the whole nerve route. TheraBand exercises 1. Hamstring stretching: Patient will be in supine lying position with the band around the sole of the foot by holding the both ends of TheraBand in both the hands after that patient will be asked to lift the leg by gently pull on the TheraBand to increase the stretch by keeping the leg straight. Patient will hold this stretch for 30-45 seconds/ 10-12 repetitions/ 3 sets. 2. Hip abduction: Patient will be in standing position then therapist will attach the band to a stable anchor point, such a door handle. Patient will stand with feet shoulder-width apart and wrap the band around ankle. By keeping feet together, patient move legs out to the sides and then back to the midline of body. Repeat this movement for 10-12 times with a hold of 30-45 seconds/ 3 sets. 3. Hip flexion: Patient will be in standing position then therapist will attach one end of the band with the patient ankle and other band will be tie to the anchor or fixed object behind the patient. Then patient will ask to move leg in forward direction to create the hip flexion. Patient will perform the exercise for 10-12 times in a set for 3 sets with a hold of 30-45 seconds. 4. Lumbar extension: Patient will Sit on floor with knees straight and one end of the band looped around the feet. Grasp the other end of the band at chest level. By Keeping back straight and upright, lean backward away from feet without arch the back, hold the position then slowly return to original position. Patient will ask to repeat the exercise for 10-12 times in a set of 3 sets with a hold 0f 30-45 seconds. 5. Trunk rotation: Anchor the band at patient’s chest height, grab it in both hands, and step away from the anchor sideways. Patient will extend arms out in front and twist torso until arms are straight out to the side (away from the anchor). Reverse the motion and perform on both sides. This motion will be repeat for 10-12 times on each side for 3 sets with a hold of 30-45 seconds. Treatment session is given to patient 3 times a week for 8 weeks.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  18-40 Years
Sciatica Pain
Bilateral/Unilateral
Disc herniation
 
 
ExclusionCriteria 
Details  Surgical Intervention
Spinal Infection
Spinal Tumor
Spinal Fracture
Known Mg Deficiency
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Numeric Pin Rating Scale
Roland Morris Disability Questionnaire
SF-36
 
Numeric Pin Rating Scale (Baseline, 8th week)
Roland Morris Disability Questionnaire (Baseline, 8th week)
SF-36
 
 
Secondary Outcome  
Outcome  TimePoints 
Serum Electrolyte Level  Baseline, 8th week 
 
Target Sample Size   Total Sample Size="112"
Sample Size from India="112" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   25/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Introduction: Sciatic pain, commonly known as sciatica, is a prevalent condition characterized by radiating pain along the sciatic nerve pathway, significantly affecting an individual’s quality of life due to discomfort, numbness, and muscle weakness.

Aim: To study the effect of transdermal magnesium and moderate intensity TheraBand training on quality of life among adults with sciatic pain. Cost-effective, non-invasive methods of treating sciatic pain are becoming more and more necessary. Investigating the synergistic effects of transdermal magnesium and moderate-intensity TheraBand training may provide an innovative approach to promote integrative pain management techniques by enhancing quality of life, lowering disability, and improving pressure pain threshold in impacted individuals.

Material and Methods: A two-group pretest-post-test randomised clinical trial will be conducted in recognised hospitals in Delhi using simple random sampling from February 2025 to February 2026. Two groups will be formed, each consisting of 56 subjects. Group A will serve as the experimental group receive a transdermal magnesium spray and TheraBand exercises. Group B, the control group, will receive sham transdermal magnesium spray and TheraBand exercises, both groups will be treated for 3 days in a week for 8 weeks. The paired t-test will be employed to assess subjective parameters within the same group, while the unpaired t-test will be used for intergroup comparisons, establishing a significance level of <0.05. This integrated approach addresses both biochemical and functional aspects, offering comprehensive rehabilitation benefits.


 
Close